Equity
€1.0m ▲ 16.3%
THERAPSYS has made a profit in every financial year since 2007.
THERAPSYS
Lifetime
19 annual accounts with figures on one time axis, 22 filings since 2004peak €405,086 (2025)
€405,086▲ 1.1%
peak €240,277 (2025)
€240,277▲ 2.6%
peak €1.0m (2025)
€1.0m▲ 16.3%
€221,117▲ 5.5%
peak 1 FTE (2015)
-not published
Board1 name since 2022
1 director
Documentsfilings and deeds
30-01-20261 day before the deadline
2025micro format
Legal-form change · Resignations & appointments 21-01Dividend €96,800Equity from €881,431 to €1.0m
Key points
from the 2025 annual accountsTurnover
≈ €610,000 estimated
The micro format states no turnover.
Position in the sector
€1.0m
More equity than 94% of companies in human health. Sector median €125,045 · 21,324 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 31,386 companies had the same profile as THERAPSYS has now. Each dot stands for 79 companies, two years later.
93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 31,386 companies, not a prediction for THERAPSYS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Legal-form change · Resignations & appointments
General meeting of 11-12-2024 · Gazette deed
Capital decrease of €146,700 to €18,600
Capital from €165,300 to €18,600 · Gazette deed
Incorporation
published on 16-05-2003 · Gazette deed
First establishment
Groenejagersveld 3, Brussels
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| THERAPSYS Brussels | €1.2m | €405,086 | 82.3% | - |
| MEDYCOR Molenbeek-Saint-Jean | €1.3m | €434,675 | 45.2% | 3.6 |
| ENDOCRINE UNIT Auderghem | €1.1m | €416,377 | 74.6% | - |
| Dokter Thomeer Tielt-Winge | €1.2m | €400,362 | 90.6% | - |
| KEMPENEERS OOGHEELKUNDE Eeklo | €1.2m | €392,509 | 80.0% | - |
| DOKTER N. BEERLANDT Holsbeek | €1.3m | €408,325 | 80.9% | - |
| DOKTER STEFAAN ALLAERT Bruges | €1.2m | €428,170 | 89.2% | - |
These companies have the same main activity as THERAPSYS: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1.1m and €1.3m, founded between 2002 and 2005.
Official details
Source: KBO- Status
- Active since 08-05-2003Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Joint committee
- 330Health institutions and services · annual accounts 30-06-2025
- Establishment unit
- 2.231.603.2791000 Brussels, since 05-05-2003
- Financial year end
- 30 June
- Peppol
- Not found in the Peppol Directory
Annual accounts to 30-06-2025
- €1.2m▲ 14.2%
- Employeeson 30-06-2025
- 1=
- Filing
- Filed on 30-01-2026, 1 day before the end of the filing period
Insights on THERAPSYS
THERAPSYS files the micro format. That format states no turnover. The gross margin rose from €211,013 in 2007 to €405,086 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about THERAPSYS
- What is the company number of THERAPSYS?
- The company number of THERAPSYS is 0480.179.593. The VAT number is the same number with BE in front: BE 0480.179.593.
- Where is THERAPSYS based?
- The registered office is at Groenejagersveld 3, 1000 Brussels.Company details
- What does THERAPSYS do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of THERAPSYS?
- THERAPSYS is a private limited company (BV).
- When was THERAPSYS founded?
- THERAPSYS was founded on 08-05-2003.
- Is THERAPSYS still active?
- Yes, THERAPSYS is an active enterprise in the KBO register.
- How many employees does THERAPSYS have?
- THERAPSYS had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does THERAPSYS fall under?
- In its 30-06-2025 annual accounts, THERAPSYS states joint committee 330 (Health institutions and services).
- What is the turnover of THERAPSYS?
- The turnover in financial year 2025 is ≈ €610,000. This figure is estimated from the gross margin of €405,086 and 31 comparable companies (NACE 86220). It probably lies between €540,000 and €850,000.
- Is THERAPSYS profitable?
- In financial year 2025, THERAPSYS made a profit of €240,277.
- Where can I find the annual accounts of THERAPSYS?
- THERAPSYS filed 22 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of THERAPSYS due?
- THERAPSYS must file the annual accounts for financial year 2026 by 31-01-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.